RNF43 expression is associated with the prognosis of various cancers and enhances the sensitivity to immunotherapy, conventional anticancer drugs, and molecular-targeted drugs by affecting signal transduction, drug metabolism, and the tumor immune microenvironment [26]. Here, RNF43 is linked to cancer.